日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Eptinezumab to prevent difficult-to-treat migraine: prospective, six-month, real-world multicenter evidence from the GRASP study group

Eptinezumab 预防难治性偏头痛:来自 GRASP 研究组的前瞻性、六个月、真实世界多中心证据

Dermitzakis, Emmanouil V; Argyriou, Andreas A; Chondrogianni, Maria; Foska, Aikaterini; Rikos, Dimitrios; Athanasopoulos, Dimitrios; Tsironis, Christos; Soldatos, Panagiotis; Koutsokera, Maria; Tsitsaras, Nikolaos; Litsardopoulos, Pantelis; Mavraki, Eleni; Vikelis, Michail

OnabotulinumtoxinA to Prevent Chronic Migraine with Comorbid Bruxism: Real-World Data from the GRASP Study Group

使用A型肉毒杆菌毒素预防伴有磨牙症的慢性偏头痛:来自GRASP研究组的真实世界数据

Argyriou, Andreas A; Dermitzakis, Emmanouil V; Chondrogianni, Maria; Foska, Aikaterini; Rikos, Dimitrios; Xiromerisiou, Georgia; Soldatos, Panagiotis; Litsardopoulos, Pantelis; Vikelis, Michail

Testing the Efficacy of Eptinezumab 100 mg in the Early Prevention of Chronic Migraine over Weeks 1 to 4: Prospective Real-World Data from the GRASP Study Group

在第 1 至 4 周内测试 Eptinezumab 100 mg 在慢性偏头痛早期预防中的疗效:来自 GRASP 研究组的前瞻性真实世界数据

Argyriou, Andreas A; Dermitzakis, Emmanouil V; Chondrogianni, Maria; Foska, Aikaterini; Rikos, Dimitrios; Soldatos, Panagiotis; Vikelis, Michail

Corrigendum: Unmet needs in the management of migraine in Greece from the perspective of medical experts: a Delphi consensus

更正:从医学专家的角度看希腊偏头痛管理中未满足的需求:一项德尔菲共识

Kourlaba, Georgia; Vikelis, Michail; Karapanayiotides, Theodoros; Solakidi, Argyro; Trafalis, Dimitrios; Lioliou, Katerina; Andriopoulos, Panagiotis; Panagiotou, Aspasia; Mitsikostas, Dimos-Dimitrios

Efficacy of single-dose galcanezumab 240 mg on episodic or refractory chronic cluster headache: prospective, 4-week, real-world evidence from the GRASP study group

单剂量 240 mg 加尔卡奈珠单抗治疗发作性或难治性慢性丛集性头痛的疗效:来自 GRASP 研究组的前瞻性、4 周真实世界证据

Vikelis, Michail; Argyriou, Andreas A; Chondrogianni, Maria; Foska, Aikaterini; Rikos, Dimitrios; Tsironis, Christos; Soldatos, Panagiotis; Koutsokera, Maria; Dermitzakis, Emmanouil V

Unmet needs in the management of migraine in Greece from the perspective of medical experts: a Delphi consensus

从医学专家的角度看希腊偏头痛管理中未满足的需求:一项德尔菲共识

Kourlaba, Georgia; Vikelis, Michail; Karapanayiotides, Theodoros; Solakidi, Argyro; Trafalis, Dimitrios; Lioliou, Katerina; Andriopoulos, Panagiotis; Panagiotou, Aspasia; Mitsikostas, Dimos-Dimitrios

The unmet needs in management, the treatment gap and the burden of migraine in Greece: a Delphi consensus and focus group study from patients' perspective

希腊偏头痛管理中未满足的需求、治疗缺口和疾病负担:一项基于患者视角的德尔菲共识和焦点小组研究

Vikelis, Michail; Kourlaba, Georgia; Barba, Lia; Bilias, Konstantinos; Barbalia, Elena; Solakidi, Argyro; Trafalis, Dimitrios; Lioliou, Katerina; Zyga, Sofia; Karapanayiotides, Theodoros; Mitsikostas, Dimos-Dimitrios

Effects of OnabotulinumtoxinA on Allodynia and Interictal Burden of Patients with Chronic Migraine

肉毒杆菌毒素A对慢性偏头痛患者的痛觉过敏和发作间期负担的影响

Argyriou, Andreas A; Dermitzakis, Emmanouil V; Rikos, Dimitrios; Xiromerisiou, Georgia; Soldatos, Panagiotis; Litsardopoulos, Pantelis; Vikelis, Michail

Results of a Web-Based Survey on 2565 Greek Migraine Patients in 2023: Demographic Data, Imposed Burden and Satisfaction to Acute and Prophylactic Treatments in the Era of New Treatment Options

2023年针对2565名希腊偏头痛患者的网络调查结果:人口统计学数据、患者负担以及在新治疗方案时代对急性期和预防性治疗的满意度

Dermitzakis, Emmanouil V; Argyriou, Andreas A; Bilias, Konstantinos; Barmpa, Evangelia; Liapi, Sofia; Rikos, Dimitrios; Xiromerisiou, Georgia; Soldatos, Panagiotis; Vikelis, Michail

Reporting Quality and Risk of Bias Analysis of Published RCTs Assessing Anti-CGRP Monoclonal Antibodies in Migraine Prophylaxis: A Systematic Review

已发表的评估抗CGRP单克隆抗体在偏头痛预防中作用的随机对照试验的报告质量和偏倚风险分析:一项系统评价

Rikos, Dimitrios; Vikelis, Michail; Dermitzakis, Emmanouil V; Soldatos, Panagiotis; Rallis, Dimitrios; Rudolf, Jobst; Andreou, Anna P; Argyriou, Andreas A